Pelvic nodal radiotherapy in Gleason grade group 5 prostate cancer.
作者信息
Cook Kiri, Kishan Amar U
机构信息
Department of Radiation Medicine, Oregon Health and Science University, Portland, OR 97239, USA.
Deparmtnet of Radiation Oncology, University of California, Suite B265, Los Angeles, CA 90095, USA.
出版信息
Transl Androl Urol. 2020 Oct;9(5):2326-2328. doi: 10.21037/tau-20-917.
Abstract
摘要
相似文献
1
Pelvic nodal radiotherapy in Gleason grade group 5 prostate cancer.Gleason 5级前列腺癌的盆腔淋巴结放疗
Transl Androl Urol. 2020 Oct;9(5):2326-2328. doi: 10.21037/tau-20-917.
2
Extended prostate biopsy scheme improves reliability of Gleason grading: implications for radiotherapy patients.扩展前列腺活检方案提高了 Gleason 分级的可靠性：对放疗患者的影响
Int J Radiat Oncol Biol Phys. 2004 Jun 1;59(2):386-91. doi: 10.1016/j.ijrobp.2003.10.014.
3
Moderately Hypofractionated Radiotherapy and Androgen Deprivation Therapy for High-risk Localised Prostate Cancer: Predictors of Long-term Biochemical Control and Toxicity.中危局限性前列腺癌的适度分割放疗联合雄激素剥夺治疗：长期生化控制和毒性的预测因素。
Clin Oncol (R Coll Radiol). 2022 Jan;34(1):e52-e60. doi: 10.1016/j.clon.2021.08.010. Epub 2021 Aug 26.
4
Serum prostate-specific antigen, clinical stage, pathologic grade, and the incidence of nodal metastases in prostate cancer.
Urology. 1994 Aug;44(2):215-20. doi: 10.1016/s0090-4295(94)80134-7.
5
Nodal Clearance Rate and Long-Term Efficacy of Individualized Sentinel Node-Based Pelvic Intensity Modulated Radiation Therapy for High-Risk Prostate Cancer.基于个体化前哨淋巴结的盆腔调强放射治疗对高危前列腺癌的淋巴结清除率及长期疗效
Int J Radiat Oncol Biol Phys. 2016 Feb 1;94(2):263-71. doi: 10.1016/j.ijrobp.2015.10.031. Epub 2015 Dec 10.
6
Phase I trial of pelvic nodal dose escalation with hypofractionated IMRT for high-risk prostate cancer.高危前列腺癌的调强适形放射治疗盆腔淋巴结剂量递增的 I 期临床试验。
Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):184-90. doi: 10.1016/j.ijrobp.2010.09.018. Epub 2010 Dec 14.
7
Early Results of Extreme Hypofractionation Using Stereotactic Body Radiation Therapy for High-risk, Very High-risk and Node-positive Prostate Cancer.立体定向体部放射治疗高危、极高危和淋巴结阳性前列腺癌的超分割早期结果。
Clin Oncol (R Coll Radiol). 2018 Jul;30(7):442-447. doi: 10.1016/j.clon.2018.03.004. Epub 2018 Mar 21.
8
Incidental Dose to Pelvic Nodal Regions in Prostate-Only Radiotherapy.仅前列腺放疗时盆腔淋巴结区域的偶然剂量。
Technol Cancer Res Treat. 2017 Apr;16(2):211-217. doi: 10.1177/1533034616661447. Epub 2016 Aug 19.
9
Prognostic impact of nodal relapse in definitive prostate-only irradiation.根治性前列腺单纯放疗中淋巴结复发的预后影响。
Radiol Med. 2018 Aug;123(8):631-637. doi: 10.1007/s11547-018-0888-1. Epub 2018 Apr 12.
10
Safety of accelerated hypofractionated whole pelvis radiation therapy prior to high dose rate brachytherapy or stereotactic body radiation therapy prostate boost.加速Hypofractionated 全骨盆放射治疗在高剂量率近距离治疗或立体定向体部放射治疗前列腺加量之前的安全性。
Radiat Oncol. 2022 Jan 20;17(1):12. doi: 10.1186/s13014-021-01976-2.
本文引用的文献
1
Is pelvic prophylactic radiotherapy in prostate cancer just right?前列腺癌的盆腔预防性放射治疗是否恰到好处？
Transl Androl Urol. 2020 Oct;9(5):2296-2298. doi: 10.21037/tau-20-881.
2
Shifting the Curtain-Can We Make Sense of the Whole Pelvis Controversy?
Int J Radiat Oncol Biol Phys. 2020 Mar 1;106(3):534-536. doi: 10.1016/j.ijrobp.2019.11.012.
3
Local Failure and Survival After Definitive Radiotherapy for Aggressive Prostate Cancer: An Individual Patient-level Meta-analysis of Six Randomized Trials.根治性放疗治疗侵袭性前列腺癌后的局部失败和生存：六项随机试验的个体患者水平荟萃分析。
Eur Urol. 2020 Feb;77(2):201-208. doi: 10.1016/j.eururo.2019.10.008. Epub 2019 Nov 10.
4
Randomized Trials and the Goldilocks Problem.
Eur Urol. 2020 Jan;77(1):11-13. doi: 10.1016/j.eururo.2019.05.002. Epub 2019 May 16.
5
Effect of Standard vs Dose-Escalated Radiation Therapy for Patients With Intermediate-Risk Prostate Cancer: The NRG Oncology RTOG 0126 Randomized Clinical Trial.标准剂量与剂量递增放疗治疗中危前列腺癌患者的效果：NRG 肿瘤学 RTOG 0126 随机临床试验。
JAMA Oncol. 2018 Jun 14;4(6):e180039. doi: 10.1001/jamaoncol.2018.0039.
6
Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy Boost and Disease Progression and Mortality in Patients With Gleason Score 9-10 Prostate Cancer.根治性前列腺切除术、外照射放疗、外照射放疗联合近距离放疗增敏与 Gleason 评分 9 - 10 前列腺癌患者的疾病进展及死亡率
JAMA. 2018 Mar 6;319(9):896-905. doi: 10.1001/jama.2018.0587.
7
Is There a Role for Pelvic Irradiation in Localized Prostate Adenocarcinoma? Update of the Long-Term Survival Results of the GETUG-01 Randomized Study.盆腔放疗在局限性前列腺腺癌中是否有作用？GETUG-01随机研究长期生存结果的更新
Int J Radiat Oncol Biol Phys. 2016 Nov 15;96(4):759-769. doi: 10.1016/j.ijrobp.2016.06.2455.
8
Prostate cancer: Elective pelvic nodal radiotherapy: is the jury still out?前列腺癌：选择性盆腔淋巴结放疗：仍无定论？
Nat Rev Urol. 2016 Jan;13(1):10-1. doi: 10.1038/nrurol.2015.283. Epub 2015 Nov 24.
9
An update of the phase III trial comparing whole pelvic to prostate only radiotherapy and neoadjuvant to adjuvant total androgen suppression: updated analysis of RTOG 94-13, with emphasis on unexpected hormone/radiation interactions.一项比较全盆腔放疗与仅前列腺放疗以及新辅助全雄激素抑制与辅助全雄激素抑制的III期试验的更新：RTOG 94-13的更新分析，重点关注意外的激素/放疗相互作用。
Int J Radiat Oncol Biol Phys. 2007 Nov 1;69(3):646-55. doi: 10.1016/j.ijrobp.2007.04.003. Epub 2007 May 24.
Zotero 插件